EXOC1 and cancer: To strengthen this hypothesis, we first performed siRNA-mediated knockdown of Sec3 (EXOC1) in the cancer cells, which showed a significant reduction in nanotubular cancer cell–endothelial cell and cancer cell–cancer cell connections.